Alexandru Stieber/LinkedIn
Dec 1, 2025, 15:32
Alexandru Stieber on a Curious Finding: GLP-1 RAs and the Risk of Optic Neuropathy
Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, posted on LinkedIn:
“A very curious research revealing a possible link between the use of GLP-1 receptor antagonists such as semaglutide or liraglutide and the risk of developing nonarteritic ischemic anterior optic neuropathy, current findings which support previous studies on the matter and that nuance the uses of such therapeutic agents.”
Title: GLP-1 RAs and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Older Patients With Diabetes
Authors: Kin Wah Fung, Fitsum Baye, Seo H. Baik, Clement J. McDonald

Read full article here.
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome